Rising cost pressures, government regulations, patent expirations, growing patient demands — pharma and life sciences companies confront a host of challenges. Yet the best-in-class companies are finding newer ways — be it through M&A, leveraging data analytics, or focusing on specialty drugs — to remain profitable. Regulatory reforms and advances in science and technology are enabling them to innovate and move forward.
What are the latest macroeconomic trends impacting the pharma and life sciences industries? And what do they mean for your business, and the procurement function? Our latest white paper, Pharma and Life Sciences: Key Procurement Trends and Opportunities, explains. It discusses the broader industry outlook — focusing on primary factors including scientific disruptors, macro-economic trends and performance catalysts — and also underlines the important role of procurement in improving a company’s strategic positioning.
A must-read for all pharma and life sciences professionals looking to understand the current industry trends and achieve sustainable growth.